The UF Health Proton Therapy Institute welcomes two physicians and a physicist to its medical team.
Adam L. Holtzman, M.D.
Dr. Holtzman is an assistant professor in the Department of Radiation Oncology at the University of Florida College of Medicine. While skilled in all external beam radiation modalities, he specializes in proton therapy for skull-based and central nervous system malignancies. He received his undergraduate, medical, and residency training from the University of Florida. An established researcher, his work has been published in multiple peer-reviewed medical journals and presented at international conferences. Dr. Holtzman has received multiple awards in recognition for his dedication to clinical care, compassion and research. He was honored as Best of American Society for Radiation Oncology 57th Annual Meeting, inducted into the Gold Humanism Honors Society, and received the Outstanding Resident Educator Award.
Raymond B. Mailhot, M.D., M.P.H.
Dr. Mailhot is an assistant professor in the Department of Radiation Oncology at the University of Florida College of Medicine. His areas of treatment and research include proton therapy for pediatric cancer and breast cancer. He completed his undergraduate and medical training at Washington University in St. Louis and post graduate training at Harvard University and New York University, where he served as chief resident. He has published multiple research articles in peer-reviewed medical journals and presented research at international medical conferences. His academic and professional honors include the J. Max Rukes Full Tuition Merit Scholarship, Washington University School of Medicine; Merit Scholarship, Harvard School of Public Health; Jonathan Mann Foreign Rotation Fellowship Award; and American Society of Clinical Oncology Conquer Cancer Fellowship Award. He serves on committee for the American Society for Radiation Oncology.
Mark Artz, Ph.D.
Dr. Artz is an assistant professor in the Department of Radiation Oncology at the University of Florida College of Medicine. He received his bachelor’s and master’s degrees from the Massachusetts Institute of Technology, where he contributed to the development of superconducting cyclotrons and gantries for proton therapy. Most recently, as an adjunct professor at the University of Tennessee and medical physicist fellow at the Provision Proton Therapy Center, Knoxville, Dr. Artz was responsible for clinical commissioning and operation of IBA and ProNova Proton and Eleckta Photon, including treatment planning, quality assurance and clinical development. He also developed a CAMPEP Master of Science degree program in Medical Physics with the University of Tennessee College of Engineering.